STF-31 5 mg | 99.92%
TargetMol
STF-31 is an inhibitor of glucose transporter 1 (GLUT1) with IC50 of 1 μM.
More Information Supplier PageSTF-31
Search Results
Radotinib 50 mg | 99.70%
TargetMol
Radotinib, and sometimes referred to by its investigational name IY5511, is a drug for the treatment of different types of Y, most notably Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) with resistance or intolerance of other tyrosine kinase Bcr-Abl inhibitors
More Information Supplier PageRadotinib
Sacubitril/Valsartan 100 mg | 99.94%
TargetMol
Sacubitril/Valsartan (LCZ696) is an orally bioavailable, dual angiotensin II receptor and neprilysin inhibitor for the treatment of hypertension and heart failure.
More Information Supplier PageSacubitril/Valsartan
Sacubitril/Valsartan 25 mg | 99.94%
TargetMol
Sacubitril/Valsartan (LCZ696) is an orally bioavailable, dual angiotensin II receptor and neprilysin inhibitor for the treatment of hypertension and heart failure.
More Information Supplier PageSacubitril/Valsartan
Tucatinib 2 mg | 99.96%
TargetMol
Irbinitinib(ARRY-380; ONT-380) is a potent and selective HER2 inhibitor (IC50: 8 nM).
More Information Supplier PageTucatinib
Tucatinib 25 mg | 99.96%
TargetMol
Irbinitinib(ARRY-380; ONT-380) is a potent and selective HER2 inhibitor (IC50: 8 nM).
More Information Supplier PageTucatinib
Tipiracil hydrochloride 25 mg | 99.45%
TargetMol
Tipiralacil is a thymidine phosphorylase inhibitor (TPI). Tipiracil is one of the active components in TAS-102, which is an anticancer drug candidate currently in clinical trials.
More Information Supplier PageTipiracil hydrochloride
Bortezomib 200 mg | 98.00%
TargetMol
Bortezomib (PS-341) is a potent 20S proteasome inhibitor (Ki: 0.6 nM, in a cell-free assay).
More Information Supplier PageBortezomib
Ramatroban 200 mg | 99.96%
TargetMol
Ramatroban (BAY u3405) is a thromboxane A(2) (TxA(2)) antagonist marketed for allergic rhinitis. It has been used in trials studying the treatment of Asthma.
More Information Supplier PageRamatroban
Ramatroban 5 mg | 99.96%
TargetMol
Ramatroban (BAY u3405) is a thromboxane A(2) (TxA(2)) antagonist marketed for allergic rhinitis. It has been used in trials studying the treatment of Asthma.
More Information Supplier PageRamatroban